To determine whether ATR overexpression could impact KRAS-driven cancer development, we focused on a cohort of LUAD patients from The Cancer Genome Atlas (TCGA) and sought to determine whether the expression level of ATR impacts overall survival (OS). Here, KRAS is linked to cancer.